BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.428,93 PKT +17,88 PKT +1,27 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
20.07.12 Novartis hold Vontobel Research
20.07.12 Novartis neutral Exane-BNP Paribas SA
19.07.12 Swisscom buy Banc of America Securities-Merrill Lynch
19.07.12 UBS overweight J.P. Morgan Cazenove
19.07.12 UBS hold Deutsche Bank AG
19.07.12 Novartis halten Independent Research GmbH
19.07.12 Novartis buy Sarasin Research
19.07.12 UBS underperform Exane-BNP Paribas SA
19.07.12 Swisscom neutral Nomura
19.07.12 ABB (Asea Brown Boveri) hold ING
19.07.12 Logitech hold Vontobel Research
19.07.12 UBS equal-weight Morgan Stanley
19.07.12 ABB (Asea Brown Boveri) buy Vontobel Research
19.07.12 UBS sell Société Générale Group S.A. (SG)
19.07.12 Novartis hold Vontobel Research
19.07.12 Novartis hold Vontobel Research
19.07.12 Novartis buy Société Générale Group S.A. (SG)
19.07.12 UBS hold Vontobel Research
19.07.12 UBS halten Independent Research GmbH
18.07.12 UBS buy Citigroup Corp.
18.07.12 UBS buy Citigroup Corp.
18.07.12 UBS neutral Sarasin Research
18.07.12 UBS hold Commerzbank Corp. & Markets
18.07.12 Logitech outperform Exane-BNP Paribas SA
18.07.12 Novartis neutral Exane-BNP Paribas SA
17.07.12 Novartis buy Deutsche Bank AG
17.07.12 Roche buy Deutsche Bank AG
17.07.12 Kühne + Nagel International neutral UBS AG
17.07.12 Kühne + Nagel International buy Nomura
17.07.12 Novartis buy Société Générale Group S.A. (SG)
17.07.12 Novartis buy UBS AG
17.07.12 Nestlé hold ING
17.07.12 Kühne + Nagel International hold Vontobel Research
17.07.12 ABB (Asea Brown Boveri) outperform Sanford C. Bernstein and Co., Inc.
17.07.12 Zurich Insurance buy Sarasin Research
16.07.12 Givaudan reduce Nomura
16.07.12 ABB (Asea Brown Boveri) buy Citigroup Corp.
16.07.12 Swisscom buy Deutsche Bank AG
16.07.12 Kühne + Nagel International neutral Sarasin Research
16.07.12 UBS underperform Exane-BNP Paribas SA